# José Luis Górriz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jose-luis-gorriz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,845 |
| Field | Diabetes Treatment and Management |
| h-index | 44 |
| i10-index | 147 |
| Last Known Institution | Universitat de València |
| OpenAlex ID | https://openalex.org/A5046692355 |
| ORCID iD | 0000-0002-1134-9051 |
| Works | 350 |

## Researcher papers

- [Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus](https://scholariq.org/papers/clinical-recommendations-to-manage-gastrointestinal-adverse-events-in-patients/)
- [Proteinuria: detection and role in native renal disease progression](https://scholariq.org/papers/proteinuria-detection-and-role-in-native-renal-disease-progression/)
- [Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study](https://scholariq.org/papers/improvement-of-mineral-and-bone-metabolism-markers-is-associated-with-better/)
- [The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics](https://scholariq.org/papers/the-dapagliflozin-and-prevention-of-adverse-outcomes-in-chronic-kidney-disease/)
- [Diabetic kidney disease: from physiology to therapeutics](https://scholariq.org/papers/diabetic-kidney-disease-from-physiology-to-therapeutics/)
- [Vascular Calcification in Patients with Nondialysis CKD over 3 Years](https://scholariq.org/papers/vascular-calcification-in-patients-with-nondialysis-ckd-over-3-years/)
- [Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial](https://scholariq.org/papers/albuminuria-lowering-effect-of-dapagliflozin-eplerenone-and-their-combination-in/)
- [The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years](https://scholariq.org/papers/the-concept-and-the-epidemiology-of-diabetic-nephropathy-have-changed-in-recent/)
- [Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality](https://scholariq.org/papers/long-term-potassium-monitoring-and-dynamics-in-heart-failure-and-risk-of/)
- [Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial](https://scholariq.org/papers/effects-of-semaglutide-with-and-without-concomitant-sglt2-inhibitor-use-in/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Researcher university

- [Universitat de València](https://scholariq.org/institutions/universitat-de-valencia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.